BackBionoid Pharma Overview

Bionoid Pharma Common Stock

Track Bionoid Pharma's common stock ($5.4K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$5399.00
↑ 0.00% YoYΔ $0.00 vs prior year quarter

Peer trimmed avg / median

Loading

Bionoid Pharma Common Stock History

Loading

Bionoid Pharma vs. peers: Common Stock Comparison

Loading

Bionoid Pharma Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Bionoid Pharma (BINP) FAQ

Bionoid Pharma posts a common stock of $5.4K as of June 2025. That compares with $5.4K in the prior-year period — up 0.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Bionoid Pharma's common stock was $5.4K. The latest reading is $5.4K — essentially flat versus a year earlier (period ending June 2025). Use the history and growth charts on this page for a longer lookback.

Common Stock is one piece of Bionoid Pharma's financial statement story. At $5.4K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BINP's common stock usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Bionoid Pharma's other metric pages and overview cover the third.